CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 55 filers reported holding CYTOSORBENTS CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,180 | -47.6% | 23,500 | 0.0% | 0.01% | -42.1% |
| Q2 2023 | $84,365 | +25.2% | 23,500 | +17.5% | 0.02% | +18.8% |
| Q1 2023 | $67,400 | +117.4% | 20,000 | 0.0% | 0.02% | +100.0% |
| Q4 2022 | $31,000 | +106.7% | 20,000 | +81.8% | 0.01% | +100.0% |
| Q3 2022 | $15,000 | -37.5% | 11,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $24,000 | -31.4% | 11,000 | +175.0% | 0.00% | -42.9% |
| Q1 2021 | $35,000 | -37.5% | 4,000 | -42.9% | 0.01% | -46.2% |
| Q4 2020 | $56,000 | 0.0% | 7,000 | 0.0% | 0.01% | -7.1% |
| Q3 2020 | $56,000 | -18.8% | 7,000 | 0.0% | 0.01% | -46.2% |
| Q2 2020 | $69,000 | +27.8% | 7,000 | 0.0% | 0.03% | +8.3% |
| Q1 2020 | $54,000 | – | 7,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skylands Capital, LLC | 815,869 | $3,141,000 | 0.46% |
| Sargent Investment Group, LLC | 499,010 | $1,921,000 | 0.36% |
| Anson Funds Management LP | 74,440 | $287,000 | 0.33% |
| One68 Global Capital, LLC | 39,241 | $151,000 | 0.33% |
| Granahan Investment Management | 678,618 | $2,613,000 | 0.12% |
| Winning Points Advisors, LLC | 30,000 | $115,000 | 0.07% |
| Avenir Corp | 150,600 | $580,000 | 0.06% |
| HighMark Wealth Management LLC | 10,000 | $38,000 | 0.04% |
| Wealthcare Advisory Partners LLC | 62,279 | $240,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 64,970 | $250,000 | 0.03% |